Bioabsorbable Stents Market Size, Share, Growth and Report 2025-2033
Market Overview:
- The global bioabsorbable stents market size reached USD 438.0 Million in 2024.
- The market is expected to reach USD 786.5 Million by 2033, exhibiting a growth rate (CAGR) of 6.72% during 2025-2033.
- North America leads the market, accounting for the largest bioabsorbable stents market share.
- Most of the market share in the biomaterial segment belongs to polymer-based bioabsorbable stents.
- The largest share of the bioabsorbable stents industry belongs to slow-absorption stents.
- Coronary artery disease holds the largest market share due to its high prevalence, which creates a strong demand for advanced treatments such as bioabsorbable stents.
- Hospitals make up the largest end-user segment. The rising number of cardiovascular diseases is driving the demand for bioabsorbable stents.
- Advances in stent technology and a growing awareness of less invasive procedures are changing the market for bioabsorbable stents.
This detailed analysis primarily encompasses industry size, business trends, market share, key growth factors, and regional forecasts. The report offers a comprehensive overview and integrates research findings, market assessments, and data from different sources. It also includes pivotal market dynamics like drivers and challenges, while also highlighting growth opportunities, financial insights, technological improvements, emerging trends, and innovations. Besides this, the report provides regional market evaluation, along with a competitive landscape analysis.
Grab a sample PDF of this report: https://www.imarcgroup.com/bioabsorbable-stents-market/requestsample
Our report includes:
- Market Dynamics
- Market Trends And Market Outlook
- Competitive Analysis
- Industry Segmentation
- Strategic Recommendations
Factors Affecting the Growth of the Bioabsorbable Stents Industry:
-
Increasing prevalence of cardiovascular diseases:
Heart disease lurks as one of the world’s deadliest foes. As a result, we must champion more advanced treatment options. Traditional metal stents offer reliable relief; however, they carry certain risks. These hazards include long-term inflammation, thrombosis, and the dreaded restenosis. Bioabsorbable stents are a revolutionary option. They support blocked arteries and dissolve gradually. This lowers the risks linked to permanent implants. This appealing feature attracts both patients and healthcare providers. They seek safer, less invasive solutions. With heart disease on the rise—thanks to aging populations, sedentary lifestyles, and unhealthy diets—demand for bioabsorbable stents is stronger than ever.
-
Advancements in stent technology:
Manufacturers are putting money into research and development for new bioabsorbable stents. These next-generation stents aim to beat earlier models. They provide better flexibility, durability, and drug-eluting features. This leads to improved arterial support and fewer complications, such as restenosis and thrombosis. Newer bioabsorbable stents use biodegradable materials that dissolve naturally in the body after supporting blood flow. This removes the need for permanent implants. It also reduces the risk of long-term complications. Also, faster-absorbing and more effective stents are increasing healthcare providers' confidence in recommending them.
-
Growing awareness and preference for minimally invasive procedures:
Patients and healthcare providers are gaining a better understanding of minimally invasive procedures, which is driving the increased use of bioabsorbable stents. Compared to metal stents, bioabsorbable stents have several benefits, including quicker recovery times, less scarring, and a reduced risk of long-term complications. Patients who prefer safer, less invasive treatments are drawn to these benefits. Healthcare systems are moving towards cost-effective treatments that reduce the need for repeat procedures, lengthy hospital stays, and extensive follow-up care. Since bioabsorbable stents dissolve gradually once the artery has healed, they minimize further complications, making them a preferred choice for both doctors and patients.
Leading Companies Operating in the Global Bioabsorbable Stents Industry:
- Abbott Laboratories
- Arterius Limited
- B. Braun SE
- Biotronik SE & Co. KG
- Boston Scientific Corporation
- Elixir Medical Corporation
- Kyoto Medical Planning Co. Ltd.
- Lepu Medical Technology (Beijing) Co. Ltd.
- Meril Life Sciences Pvt. Ltd.
- Reva Medical LLC
- Terumo Corporation
Bioabsorbable Stents Market Report Segmentation:
Breakup By Biomaterial:
- Polymer-based Bioabsorbable Stents
- Metal-based Bioabsorbable Stents
Polymer-based bioabsorbable stents exhibit a clear dominance in the market accredited to their superior flexibility and biocompatibility, which minimize the risk of arterial irritation and promote better healing.
Breakup By Absorption Rate:
- Slow-Absorption Stents
- Fast-Absorption Stents
Slow-absorption stents represent the largest segment, as they provide prolonged support to the artery, reducing the likelihood of vessel recoil and late thrombosis.
Breakup By Region:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
North America dominates the market owing to the existence of an advanced healthcare infrastructure and the presence of leading device manufacturers in the region.
Research Methodology:
The report employs a comprehensive research methodology, combining primary and secondary data sources to validate findings. It includes market assessments, surveys, expert opinions, and data triangulation techniques to ensure accuracy and reliability.
Note: If you require specific details, data, or insights that are not currently included in the scope of this report, we are happy to accommodate your request. As part of our customization service, we will gather and provide the additional information you need, tailored to your specific requirements. Please let us know your exact needs, and we will ensure the report is updated accordingly to meet your expectations.
About Us:
IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.
Contact Us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian